CAR T moves beyond cancer, targeting autoimmune disease with immune system reset - Medical Xpress
CAR T cell therapy, originally developed to treat blood cancers, is now being tested in clinical trials for various autoimmune diseases. Patients like Jan Janisch-Hanzlik are participating in these trials, hoping the treatment can reset their immune systems.
Why it matters
This represents a significant potential breakthrough in medical science, offering a new therapeutic approach for chronic conditions that currently lack effective treatments.
CAR T moves beyond cancer, targeting autoimmune disease with immune system reset
The article relies on medical reporting and patient experience, maintaining a balanced view of both the potential benefits and the inherent risks.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in